Tag: fast melt tablets market size

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Fast Melt Tablets Market Be Worth By 2029?

In recent times, there has been a significant surge in the market size of fast melt tablets. It is projected to increase from $4.96 billion in 2024 to about $5.33 billion in 2025, following a Compound Annual Growth Rate (CAGR) of 7.5%. Factors contributing to the notable growth over the historic period include an aging population, a surge in chronic illnesses, an uptick in the self-medication trend, the expansion of the pharmaceutical sector, and rising disposable incomes.

The market for quick dissolve tablets is projected to experience robust growth in the forthcoming years. The market size is poised to reach “$7.18 billion by 2029” with a compound annual growth rate (CAGR) of 7.7%. The surge during the anticipated period is attributed to factors like the increasing occurrence of dysphagia, heightened preference for over-the-counter medication, growth of e-commerce, heightened demand for orally dissolvable drugs, and improving healthcare facilities. Significant trends predicted in the future include advancements in technology, novel formulation methods, use of nanotechnology, a move towards plant-derived excipients, and intelligent drug delivery systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Which Key Factors Are Fueling Growth In The Fast Melt Tablets Market?

The fast melt tablets market is projected to expand due to the escalating cases of heart attacks. A heart attack is a medical crisis resulting from an obstruction of the blood supply to the cardiac muscle, typically due to a blood clot or the accumulation of plaque in the coronary arteries. Factors such as increased consumption of processed foods leading to elevated cholesterol levels and heightened arterial plaque accumulation are contributing to the growing prevalence of heart attacks. Fast melt tablets allow for swift drug absorption supporting faster distribution of vital medications such as aspirin or nitroglycerin, which helps to prevent additional harm during a heart attack. They enhance patient outcomes by reestablishing blood supply and lessening the probability of severe complications. According to the British Heart Foundation’s report in January 2024, a UK-based cardiovascular research charity, over 39,000 premature deaths in England were due to cardiovascular conditions such as heart attacks, coronary heart disease, and stroke in 2022, translating to an average of 750 deaths weekly, the highest figure ever recorded. Consequently, the escalating occurrence of heart attacks is fuelling the fast melt tablets market’s expansion.

How Is The Fast Melt Tablets Market Segmented Across Key Categories?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

What Key Trends Are Driving Growth In The Fast Melt Tablets Market?

Major firms in the quick dissolve tablet industry are prioritizing the creation of novel products such as quick dissolve tablets for greater patient comfort and quicker medication absorption. These Rapid Dissolving Tablets (RDTs) are solid medicine forms that are designed to swiftly dissolve in the mouth, eliminating the necessity for water. For example, Melt Pharmaceuticals, a US-based clinical-stage pharmaceutical firm, rolled out Melt 300 in December 2022. This advanced quick-dissolving tablet formulation was designed specifically for effective sedation. Comprised of midazolam (3 mg) and ketamine (50 mg), this inventive under-the-tongue quick-dissolving tablet ensures immediate effect and efficient sedation without the requirement for intravenous application. Melt 300 caters to the increasing demand for non-invasive, patient-friendly sedation options, improving procedural convenience while optimizing clinical workflows.

Which Firms Are Driving Innovation Within The Fast Melt Tablets Market?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

How Do Regional Dynamics Influence The Fast Melt Tablets Market Performance?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Estimated Industry Valuation for the Alexipharmic Drugs Sector?#_x000D_

The rapid-dissolve tablet industry has seen robust growth in recent years. The market value is expected to rise from $4.96 billion in 2024 to $5.33 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.5%. Factors such as an increase in the elderly population, a surge in chronic diseases, the trend of self-medication, the growth of the pharmaceutical industry, and higher disposable income have contributed to the historic growth._x000D_

_x000D_

In the coming years, the market size for fast melt tablets is anticipated to witness robust growth. It is forecasted to reach “$7.18 billion in 20229, expanding at a compound annual growth rate (CAGR) of 7.7%. This growth over the forecast period is caused by several factors such as increased incidences of dysphagia, rising preferences for OTC medications, enhanced e-commerce involvement, increasing demand for orally dissolving medications, and an increase in healthcare infrastructure. Key trends for the forecast period are technological advancements, novel formulation methods, the use of nanotechnology, a shift towards plant-based excipients, and intelligent drug delivery systems._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp_x000D_

_x000D_

#What Forces Are Driving The Growth Of The Alexipharmic Drugs Market?#_x000D_

The upward trend in fatalities resulting from drug overdosages is anticipated to drive the expansion of the alexipharmic drugs market. A drug overdose typifies the ingestion of a substance exceeding the body’s capacity to handle it, frequently leading to harmful consequences or death. The death toll from drug overdoses incorporates factors such as access to lethal substances, socioeconomic divides, mental health problems, and insufficient availability of addiction therapy and harm reduction services. Alexipharmic drugs play a vital part in reducing death rates by neutralizing the toxic impacts of drugs in overdose situations, thus averting or lessening deaths. For example, data from the Office for National Statistics for December 2023 showed that in England and Wales, there were 4,907 deaths from drug poisoning in 2022, a rise from 4,859 in 2021. Almost half of these were linked to opiates (46.1%; 2,261 deaths), while deaths associated with cocaine increased by 2.0% to 857, indicating a sequential yearly rise. Consequently, the increase in fatalities due to drug overdoses is boosting the alexipharmic drugs market._x000D_

_x000D_

_x000D_

The fast melt tablets market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types _x000D_

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications_x000D_

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable_x000D_

4) By Age Group: Adult, Pediatrics, Geriatrics_x000D_

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

_x000D_

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics _x000D_

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors _x000D_

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives _x000D_

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines _x000D_

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics _x000D_

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics _x000D_

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors _x000D_

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids _x000D_

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole _x000D_

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics_x000D_

_x000D_

#What Trends Are Currently Influencing Growth In The Alexipharmic Drugs Market?#_x000D_

Major players in the fast melt tablets market are striving to innovate by producing products like rapidly dissolving tablets for improved patient comfort and quicker drug absorption. Rapidly dissolving tablets (RDTs) are solid dosages engineered to quickly dissolve in the mouth without requiring water. For example, in December 2022, Melt Pharmaceuticals, a clinical-stage pharmaceutical firm based in the US, introduced Melt 300, an advanced fast-melting tablet formulation aimed at efficient sedation. This ground-breaking sublingual fast-melting tablet, which combines midazolam (3 mg) and ketamine (50 mg), dissolves rapidly, ensuring swift onset and potent sedation without intravenous administration. Melt 300, which caters to the climbing demand for patient-friendly, needle-free sedation alternatives, enhances procedural ease while improving clinical procedures._x000D_

_x000D_

#Which Companies Currently Dominate The Competitive Landscape In The Alexipharmic Drugs Industry?#_x000D_

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc. _x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report_x000D_

_x000D_

#Which Geographic Regions Are Driving Demand In The Alexipharmic Drugs Market?#_x000D_

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Milestones in the Fast Melt Tablets Market’s Growth Trajectory From 2025 To 2034?#_x000D_

There has been substantial growth in the market size of fast melt tablets in the past few years. The market is projected to expand from $4.96 billion in 2024 to $5.33 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this surge during the historical period include an increase in the elderly population, higher prevalence of chronic illnesses, the growing trend of self-medication, expansion in the pharmaceutical industry, and a rise in disposable income._x000D_

_x000D_

The market size for fast melt tablets is projected to experience substantial expansion in the coming years, reaching $7.18 billion in 2029, with a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecasted period can be credited to factors such as the growing incidences of dysphagia, an increased inclination for over-the-counter medications, burgeoning e-commerce sector, heightened demand for orally dissolving drugs, and an improving healthcare infrastructure. Moreover, anticipated trends during this period include technological advancement, inventive drug formulation methods, the incorporation of nanotechnology, a shift towards plant-based excipients, and intelligent drug delivery systems._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Fast Melt Tablets Industry?#_x000D_

The escalating frequency of heart attacks is projected to spur the growth of the fast melt tablets market in the future. A heart attack is a medical crisis characterized by blocked blood flow to the heart muscle, typically caused by a blood clot or accumulation of plaque in the coronary arteries. The heart attack rate is increasing owing to greater consumption of processed foods, resulting in elevated cholesterol levels and accumulation of arterial plaque. Fast melt tablets offer speedy drug absorption, facilitating faster delivery of crucial medications such as aspirin or nitroglycerin, which can mitigate further harm during a heart attack. This rapid intervention helps improve patient outcomes by re-establishing blood circulation and reducing the likelihood of serious complications. For example, the British Heart Foundation reported in January 2024 that in 2022, over 39,000 people in England died prematurely from cardiovascular conditions such as heart attacks, coronary heart disease, and stroke, averaging 750 deaths per week—the highest recorded figure till date. Consequently, the increasing frequency of heart attacks is fueling the expansion of the fast melt tablets market._x000D_

_x000D_

#How Is the Fast Melt Tablets Market Segmented?#_x000D_

The fast melt tablets market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types _x000D_

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications_x000D_

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable_x000D_

4) By Age Group: Adult, Pediatrics, Geriatrics_x000D_

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

_x000D_

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics _x000D_

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors _x000D_

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives _x000D_

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines _x000D_

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics _x000D_

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics _x000D_

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors _x000D_

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids _x000D_

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole _x000D_

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Fast Melt Tablets Market Growth?#_x000D_

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Fast Melt Tablets Industry?#_x000D_

Leading firms in the fast melt tablets market are prioritizing the creation of ground-breaking products such as quickly dissolving tablets to improve patient experience and expedite drug absorption. Rapidly dissolving tablets (RDTs) are engineered solid doses meant to dissolve speedily in the mouth, eliminating the need for water. Case in point, Melt Pharmaceuticals, an American clinical-stage pharma firm, introduced Melt 300 in December 2022, an advanced fast-melting tablet formula designed for proficient sedation. This pioneering sublingual fast-melting tablet combines midazolam (3 mg) and ketamine (50 mg). It dissolves promptly, guaranteeing a quick onset and effective sedation without needing intravenous delivery. By catering to the increasing demand for needleless, user-friendly sedation methods, Melt 300 significantly improves procedural ease and optimizes clinical procedures._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report_x000D_

_x000D_

#How Is the Fast Melt Tablets Market Defined and What Are Its Core Parameters?#_x000D_

Fast melt tablets are oral dosage forms designed to dissolve quickly in the mouth without the need for water. They offer a convenient option for patients who have difficulty swallowing traditional tablets. These tablets disintegrate rapidly, typically within seconds, upon contact with saliva. Fast melt technology is often used in pediatric, geriatric, and travel-friendly medications._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23398_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Fast Melt Tablets Market from 2024 to 2025?

The market for fast melt tablets has seen impressive growth over the past few years. The market value is anticipated to grow from $4.96 billion in 2024 to $5.38 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.4%. The significant expansion during the historic period owes much to the growing elderly population, an upsurge in chronic diseases, an inclination towards self-medication, the widening scope of the pharmaceutical industry, and a rise in disposable income.

What Is the Projected Market Size of the Fast Melt Tablets Market?

In the following years, there is projected to be substantial growth in the fast melt tablets market, anticipated to reach $7.35 billion by 2029, at an 8.1% compound annual growth rate (CAGR). The anticipated escalation throughout this forecast period is attributable to factors such as the increasing incidence of dysphagia, the preference trend for over-the-counter medications, expanding online market penetration, a surge in demand for orally dissolving medications, and improved health care infrastructure. Key trends predicted to shape this forecast period include technological breakthroughs, fresh formulation methods, the introduction of nanotechnology, a shift towards botanical excipients, and advanced drug delivery systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Who are the Major Competitors in the Fast Melt Tablets Market Outlook?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

What Is Fueling Growth in the Fast Melt Tablets Market?

The escalation in heart attack occurrences is anticipated to fuel the expansion of the fast melt tablets market in the future. Heart attacks represent a medical crisis resulting from the blockage of blood circulation to the heart muscle, usually caused by a blood clot or the accumulation of plaque in the coronary arteries. The surge in heart attack incidents attributes largely to the increased intake of processed foods leading to elevated cholesterol and arterial plaque accumulation. Fast melt tablets offer a swiftly absorbing drug solution that facilitates quicker delivery of vital drugs such as aspirin or nitroglycerin, minimizing further damage in the event of a heart attack and enhancing patient results through the restoration of blood circulation and decreased risk of major complications. For instance, as per the British Heart Foundation, a cardiovascular research charity in the UK, it was reported that over 39,000 premature deaths in England occurred in 2022 due to cardiovascular issues like heart attacks, coronary heart disease, and stroke – averaging 750 deaths weekly. These numbers represent the highest ever recorded. Thus, the upward trend in heart attacks promotes the growth of the fast melt tablets market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

Which Fast Melt Tablets Market Segments Are Growing the Fastest?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

Which Industry Trends Are Shaping the Future of the Fast Melt Tablets Market?

Major firms in the fast melt tablets market are concentrating their efforts on creating innovative products like rapidly dissolving tablets for improved patient comfort and quicker medication absorption. Rapidly dissolving tablets (RDTs) are a type of solid dosage that is designed to dissolve fast in the mouth without requiring water. For example, Melt Pharmaceuticals, a clinical-stage pharmaceutical company based in the United States, introduced Melt 300, a state-of-the-art fast-melting tablet formulation designed specifically for efficient sedation, in December 2022. Composed of midazolam (3 mg) and ketamine (50 mg), this ground-breaking sublingual fast-melting tablet dissolves instantly, guaranteeing a quick onset and efficient sedation without the necessity for intravenous administration. By offering a needle-free, patient-friendly sedation alternative, Melt 300 is catering to the increasing demand and simultaneously improving procedural comfort and optimizing clinical processes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

Which Countries Are Leading the Fast Melt Tablets Market?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23398

This Report Delivers Insight On:

1. How big is the fast melt tablets market, and how is it changing globally?

2. Who are the major companies in the fast melt tablets market, and how are they performing?

3. What are the key opportunities and risks in the fast melt tablets market right now?

4. Which products or customer segments are growing the most in the fast melt tablets market?

5. What factors are helping or slowing down the growth of the fast melt tablets market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!

What Are the Key Projections for the CAGR of the Fast Melt Tablets Market Size From 2025 to 2034?

The market for fast melt tablets has witnessed robust growth in the past few years. From $4.96 billion in 2024, it is predicted to rise to $5.38 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The expansion in the historic period is due to factors such as the growing elderly population, a surge in chronic illnesses, an upward trend in self-medication, the enlargement of the pharmaceutical domain, and an increase in disposable income.

The market size for fast melt tablets is forecasted to experience substantial growth in the coming years, reaching $7.35 billion by 2029, with a compound annual growth rate (CAGR) of 8.1%. The hike in forecasted size is due to factors like an increase in dysphagia cases, a trend for over the counter medicines, the expansion of e-commerce, growing demand for orally dissolvable medication, and advancements in healthcare infrastructure. Notable trends in the future projection encompass technology improvements, the inception of inventive formulation methodologies, the inclusion of nanotech, inclination towards plant-derived fillers, and the adoption of intelligent drug delivery systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Fast Melt Tablets Market?

The escalating frequency of heart attacks is predicted to stimulate the expansion of the fast melt tablets market in the near future. A heart attack is a medical crisis that takes place when the blood supply to the heart muscle is obstructed, often due to a blood clot or accumulation of plaque in the coronary arteries. The rising number of heart attacks is linked to the increased intake of processed foods that results in elevated cholesterol levels and arterial plaque accumulation. Fast melt tablets offer swift drug absorption, facilitating faster delivery of crucial medicines like aspirin or nitroglycerin which can help mitigate further harm during a heart attack, enhancing patient results by resuming blood flow and lowering the chance of serious complications. For example, the British Heart Foundation, a UK-based cardiovascular research charity, reported in January 2024 that more than 39,000 people in England died prematurely from cardiovascular disorders such as heart attacks, coronary heart disease, and stroke in 2022, equating to around 750 deaths per week. This number represents the highest recorded figure. Therefore, the escalating frequency of heart attacks is fueling the growth of the fast melt tablets market.

Which Primary Segments of the Fast Melt Tablets Market Are Driving Growth and Industry Transformations?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

Which Regions Are Key Players in the Growth of the Fast Melt Tablets Market?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Fast Melt Tablets Industry?

Major firms in the fast melt tablets market are concentrating on creating groundbreaking products like rapidly dissolving tablets to improve patient comfort and speed up drug absorption. Rapidly dissolving tablets (RDTs) are a type of solid medication engineered to dissolve quickly in the mouth without the need for water. For example, in December 2022, the US-based clinical-stage pharmaceutical company Melt Pharmaceuticals debuted Melt 300, an advanced fast-melting tablet formulation made for effective sedation. By combining 3 mg of midazolam and 50 mg of ketamine, this pioneering sublingual fast-melting tablet rapidly dissolves, guaranteeing swift onset and potent sedation without needing an intravenous delivery. With Melt 300, the firm is aiming to cater to the increasing need for needle-free, patient-friendly sedation alternatives, thus improving procedural ease and optimizing clinical processes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

What Parameters Are Used to Define the Fast Melt Tablets Market?

Fast melt tablets are oral dosage forms designed to dissolve quickly in the mouth without the need for water. They offer a convenient option for patients who have difficulty swallowing traditional tablets. These tablets disintegrate rapidly, typically within seconds, upon contact with saliva. Fast melt technology is often used in pediatric, geriatric, and travel-friendly medications.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23398

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model